术前静脉标测超声预测自体动静脉内瘘成熟的可靠性
回顾性分析199例上肢自体动静脉内瘘,评估术前静脉标测超声预测内瘘成熟的价值。多因素分析显示最大靶静脉直径及>3 mm均不能预测成熟,高BMI与不成熟相关。结论认为常规术前静脉标测不能预测内瘘成熟。
要点
- 术前静脉标测超声不能预测自体动静脉内瘘的成熟。
- 高BMI与内瘘不成熟独立相关。
- 静脉直径与长期通畅率无关联。
核心结论
- 常规术前静脉标测超声不能预测自体动静脉内瘘的初次成熟。
- 本研究未发现临床有用的内瘘成熟预测因素。
研究设计与样本
- 回顾性临床研究,纳入199例上肢自体动静脉内瘘,由三位专科血管外科医生创建,随访5年。
主要发现
- 内瘘成熟(可触及震颤和/或成功穿刺提供400 mL/min流量)率为67%。
- 中位随访15个月(四分位距26个月),初次功能通畅率39.1%±0.6%,初次辅助通畅率94.5%±0.6%,次级通畅率97.9%±0.5%。
- 静脉直径与长期通畅率无关联。
临床怎么用
- 不应仅依赖术前静脉标测超声的静脉直径来决定是否创建自体动静脉内瘘。
- 对于高BMI患者,应警惕内瘘不成熟风险并加强监测。
局限性
- 回顾性设计可能引入选择偏倚。
- 单中心研究,由三位外科医生操作,结果外推性受限。
- 样本量有限,未发现其他预测因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autogenous arteriovenous fistula creation is the preferred route for vascular access for hemodialysis. Although preoperative venous mapping ultrasonography has been advocated as an operative planning adjunct and recently incorporated into the Society for Vascular Surgery clinical guidelines, controversy remains regarding its usefulness for predicting access success. The purpose of the present retrospective clinical study was to test the hypothesis that vein size measured on routine preoperative venous mapping is a poor predictor of primary fistula maturation. METHODS: Consecutive upper extremity autogenous arteriovenous fistulas created by three dedicated vascular surgeons were retrospectively reviewed. The demographic characteristics, preoperative venous mapping, functional maturation, and patency were analyzed. The clinically relevant variables were tested for predictive significance using a logistic regression model. RESULTS: A total of 199 upper extremity autogenous arteriovenous fistulas had been created during a 5-year period. Patients were aged 70 ± 16 years (range, 20-96 years), and 62% were men. Most had already been undergoing dialysis before fistula creation (83%), usually via a tunneled central venous catheter (62%). Radial-cephalic, brachial-cephalic, and brachial-basilic arteriovenous fistulas had been created in 82 patients (41%), 76 patients (38%), and 10 patients (5%), respectively. Fistula maturation, defined as a palpable thrill and/or successful cannulation of the fistula with the ability to deliver a flow rate of 400 mL/min, was achieved in 67% of the patients. A higher body mass index was associated with nonmaturation on both univariate and multivariate analyses (success, 28.6 ± 7.7 kg/m2; vs failed, 31.6 ± 9.4 kg/m2; P = .029; odds ratio [OR], 1.06; 95% confidence interval [CI], 1.02-1.10; P < .01). On univariate analysis, the maximum target vein diameter assessed by preoperative venous mapping was slightly larger in the group achieving successful maturation (2.9 ± 1.1 mm vs 2.6 ± 0.9 mm; P = .014). However, neither the maximum target vein diameter nor a target vein size >3 mm was significantly predictive of maturation on multivariate analysis (maximum vein diameter: OR, 0.65; 95% CI, 0.35-1.22; P = .176; vein size >3 mm: OR, 0.91; 95% CI, 0.32-2.60; P = .857). After a median follow-up of 15 months (interquartile range, 26 months), the primary functional patency, primary-assisted patency, and secondary patency rates were 39.1% ± 0.6%, 94.5% ± 0.6%, and 97.9% ± 0.5%. No association of vein diameter with long-term patency was found. CONCLUSIONS: Despite the national fistula-first initiatives, most patients still undergo access via catheter at the initiation of hemodialysis. The use of routine preoperative venous mapping does not predict successful primary maturation. Also, no clinically useful predictor of fistula maturation was identified in the present study.
引用
- El Khoury R, Russeau AP, Patel N, et al. Reliability of preoperative venous mapping ultrasonography in predicting for autogenous arteriovenous fistula maturation. J Vasc Surg. 2020. PMID: 33091513. doi:10.1016/j.jvs.2020.09.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。